Logotype for Martin Midstream Partners L.P.

Martin Midstream Partners (MMLP) Q2 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Martin Midstream Partners L.P.

Q2 2026 earnings summary

22 Jul, 2026

Executive summary

  • Adjusted EBITDA for 2Q 2026 was $27.9 million, up from $27.1 million in 2Q 2025, reflecting stable operational performance across segments.

  • Year-to-date (YTD) 2Q 2026 Adjusted EBITDA was $48.7 million, down from $55.0 million YTD 2Q 2025, primarily due to lower Sulfur Services and Transportation segment results.

  • Net income for 2Q 2026 was $2.6 million, compared to a net loss of $2.4 million in 2Q 2025; net loss for the first half of 2026 was $4.1 million versus $3.4 million loss in the prior year period.

  • Outperformance in three of four operating segments offset continued weakness in the fertilizer division.

  • Quarterly cash distribution declared at $0.005 per common unit, payable August 14, 2026.

Financial highlights

  • Q2 2026 revenues rose to $213.6 million, up from $180.7 million in Q2 2025.

  • Operating income for Q2 2026 was $19.3 million, up from $14.9 million in Q2 2025.

  • Transportation segment Adjusted EBITDA for 2Q 2026 was $8.0 million, down from $8.5 million in 2Q 2025; YTD 2Q 2026 was $14.0 million, down from $16.5 million YTD 2Q 2025.

  • Terminalling & Storage Adjusted EBITDA for 2Q 2026 was $9.5 million, up from $8.4 million in 2Q 2025; YTD 2Q 2026 was $16.6 million, up from $16.1 million YTD 2Q 2025.

  • Sulfur Services Adjusted EBITDA for 2Q 2026 was $8.7 million, down from $9.7 million in 2Q 2025; YTD 2Q 2026 was $15.5 million, down from $21.2 million YTD 2Q 2025.

Outlook and guidance

  • Full-year 2026 Adjusted EBITDA guidance is $90.0 million, revised down from a prior estimate of $104.4 million.

  • Maintenance capital expenditures and plant turnaround costs for 2026 are projected at $27.7 million.

  • Fertilizer division weakness expected to persist through year-end, but pure sulfur business anticipated to offset some pressure.

  • DSM Semichem joint venture generated first sales; stronger sales activity expected in 2027.

  • Total distributable cash flow for 2026 is forecast at $8.3 million.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more